反应 #1519146
ord-2c87197585444fc8a864d8e4bfcdd314
反应方程式
compound
trans-1-{2-[(3,5-dibromobenzyl)oxy]-2,3-dihydro-1H-inden-1-yl}piperazine dihydrochloride
diisopropylethylamine
5-(chloromethyl)-2,4-dihydro-3H-1,2,4-triazol-3-one
→
expected product
trans-5-[(4-{2-[(3,5-Dibromobenzyl)oxy]-2,3-dihydro-1H-inden-1-yl}piperazin-1-yl)methyl]-2,4-dihydro-3H-1,2,4-triazol-3-one
反应物
试剂
无
反应条件
详细条件
See reaction.notes.procedure_details.
后处理
- 1其他prepared
- 2其他evaporated to dryness
- 3其他The residue obtained
- 4洗涤washed
- 5其他dried
- 6过滤filtered
- 7其他evaporated
- 8其他The oil obtained
- 9其他is purified by flash chromatography on silica
实验过程
After reconversion to the base, the compound obtained in Step C of Example 1 (2.14 mmol) is dissolved in 30 ml of dimethylformamide. There are added 0.75 ml (4.28 mmol) of diisopropylethylamine and 314 mg (2.35 mmol) of 5-(chloromethyl)-2,4-dihydro-3H-1,2,4-triazol-3-one prepared according to the method described in Tetrahedron Letters, 2000, 41, 8661. The mixture is stirred for 12 hours at ambient temperature and then evaporated to dryness. The residue obtained is taken up in dichloromethane, washed, dried, filtered and evaporated. The oil obtained is purified by flash chromatography on silica to yield the expected product.